Silexan in the Treatment Of Posttraumatic Stress Disorder Trial
NCT06412757
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
278
Enrollment
OTHER
Sponsor class
Conditions
Post Traumatic Stress Disorder
Interventions
DRUG:
Silexan
OTHER:
Placebo
Sponsor
Deakin University
Collaborators
[object Object]
[object Object]